Skip to main content
Northwestern University Feinberg School of Medicine
Department of Medicine

Hematology and Oncology

About Us

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

“Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.

See All Faculty

Curt M Horvath

Professor of Weinberg College of Arts and Sciences, Medicine (Hematology and Oncology) and Microbiology-Immunology

Interferon, STAT

David J VanderWeele

Assistant Professor of Medicine (Hematology and Oncology)

Dr. VanderWeele did his medical and research training at the University of Chicago, where he developed a research program characterizing the heterogeneity and evolution of the cancer genome. He moved to the National Cancer Institute in Bethesda, MD, where he continued to seek to improve the treatment of prostate cancer based on patients’ specific genetic changes. He returned to Chicago in 2018 to join the GU cancer team at Northwestern University, where he continues to translate discoveries made at the bench into improved therapies in the clinic.

Meejeon Roh

Research Assistant Professor of Medicine (Hematology and Oncology)

Understanding prostate cancer using molecular biology approaches in combination with transgenic mouse model has been the main focus of my independent and collaborative research. I have an extensive expertise in mouse models as well as molecular characteristics of cancer cells. My ultimate research goal is to translate what we have learned in the laboratory setting into clinically relevant therapy, which is evidenced by my grant supports oriented to translational research. Recently, I have been working with Dr. Schaeffer to understand the molecular alterations behind the racial disparity of Afr...

Jayesh Mehta

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Seema Singhal

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Robert J Lewandowski

Professor of Radiology (Vascular and Interventional Radiology), Medicine (Hematology and Oncology) and Surgery

I am primarily interested in loco-regional therapies to treat primary and secondary liver cancers. I am involved in both pre-clinical and clinical studies along these lines. I am also very interested in the use of IVC filters in patients with venous thromboembolic disease.

Shuo Ma

Associate Professor of Medicine (Hematology and Oncology)

Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents f...

Jane N Winter

Professor of Medicine (Hematology and Oncology)

Hodgkin's disease, Leukemia, Lymphoma

Panagiotis Ntziachristos

Assistant Professor of Biochemistry and Molecular Genetics and Medicine (Hematology and Oncology)

The Ntziachristos laboratory studies the mechanistic aspects of oncogenesis with an emphasis on transcriptional and epigenetic regulation of acute leukemia. Up to 25% of children with Acute Lymphoblastic Leukemia will fail frontline therapy and their prognosis is dismal. Cure rates for patients relapsing on therapy are approximate 20%. While patients with later relapses have a better prognosis, the majority eventually succumbs to the disease (overall cure rate 40 to 50%). Important questions in our laboratory are related to how oncogenes interact with each other and with epigenetic modulators ...

Contact Us

We welcome your questions and comments.

Learn More

Diversity and Inclusion

The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.

Learn More

Housestaff Research Portal

Physician-Scientist Training & Resources

We offer a wide range of resources, mentorship opportunities and formal training programs to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.

VISIT THE STARZL ACADEMY SITE

Giving

Support What We Do

Terri Dillon

We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.

Make an online donation

Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.

Back to top